spacer
home > ict > winter 2020 > think of the children: clinical trial considerations at home
PUBLICATIONS
International Clinical Trials

Think of the Children: Clinical Trial Considerations at Home




I recall writing my nursing degree dissertation 30 years ago on the ‘Passive Role of the Patient’. I was concentrating on diabetic patients in hospital undergoing treatment for reasons other than their diabetes. Management of their diabetes was taken away from them the moment they put on a gown and slippers; upon discharge from hospital, control returned and they resumed as masters of their condition! Now working in clinical trials, I am pleased to see that the terms ‘patient centricity’ and ‘patient empowerment’ are becoming common in our day-to-day language.

The time when all clinical trial visits were conducted at site has passed. We now see a hybrid between the site and home. The associated popularity of mobile research nursing services is widely seen as a positive move. We can now design clinical trials to better suit the needs and desires of the patients and give sites the support they deserve.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Illingworth Research Group is a provider of patient-centric clinical research solutions. This can be, but is not exclusive to, mobile research nursing, patient concierge, and medical photography. Services are operational in 45 countries and concentrate on taking the trial to the patient or making trial participation easier and more accessible to patients and their families.

illingworthresearch.com
Print this page
Send to a friend
Privacy statement
News and Press Releases

Symphony Health to provide free access to new Metys COVID-19 Module for U.S. based life sciences industry during pandemic

RALEIGH, N.C., April 08, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge.
More info >>

White Papers

Sourcing Commercial Drugs for Clinical Trials: US vs. EU Understanding the Differences

Myoderm

Sourcing commercial drugs for clinical trials is a dynamic process. There are many factors to consider: single source or regional sourcing, strategy, price, supply availability, lead times, and documentation are just a few. In the past, there were fewer clinical trials that required commercial drug sourcing, so demand was not as high. Today, the demand for commercial drugs in clinical trials has greatly increased and, as a result, inventory is tighter, orders are monitored more closely by manufacturers, and lead times have increased. This report highlights the key differences in sourcing from the US and EU.
More info >>

 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement